“…The resulting scaffolds may be capable of overcoming drug resistance while also increasing activity and binding affinity [ [38] , [39] , [40] , [41] ]. Based on the aforementioned hypotheses and our continued endeavor towards the synthesis of heterocycles [ [42] , [43] , [44] , [45] , [46] , [47] , [48] , [49] , [50] , [51] , [52] , [53] , [54] , [55] , [56] , [57] , [58] , [59] , [60] , [61] , [62] , [63] , [64] , [65] , [66] , [67] , [68] , [69] , [70] , [71] , [72] ] we report herein the synthesis of some thiazoles, bis(thiazoles), and [ 1 , 2 , 4 ]triazolo[3,4- b ] [ 1 , 3 , 4 ]thiadiazines linked to hydrazinyl- N -(5-methylisoxazol-3-yl)benzenesulfonamide moiety as novel hybrid molecules and evaluation their bioactivities against different bacterial strains and fungal strains; in an attempt to conquer sulfonamide resistance and find novel therapeutic options. Furthermore, the potential binding interactions of the novel compounds with the active sites of different target enzymes were investigated using molecular docking simulations.…”